Curocell, Inc. engages in the development of anticancer immune cell treatments. It specializes in CAR-T cell therapy. The company was founded by Gun-Soo Kim, Hyun-Bo Sim, and Chan-Hyuk Kim on December 1, 2016 and is headquartered in Daejeon, South Korea.